Page last updated: 2024-10-31

neostigmine and Alogia

neostigmine has been researched along with Alogia in 1 studies

Neostigmine: A cholinesterase inhibitor used in the treatment of myasthenia gravis and to reverse the effects of muscle relaxants such as gallamine and tubocurarine. Neostigmine, unlike PHYSOSTIGMINE, does not cross the blood-brain barrier.
neostigmine : A quaternary ammonium ion comprising an anilinium ion core having three methyl substituents on the aniline nitrogen, and a 3-[(dimethylcarbamoyl)oxy] substituent at position 3. It is a parasympathomimetic which acts as a reversible acetylcholinesterase inhibitor.

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19901 (100.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Teuber, HL1

Other Studies

1 other study available for neostigmine and Alogia

ArticleYear
Functional recovery after lesions of the nervous system. II. Recovery of function after lesions of the central nervous system: history and prospects.
    Neurosciences Research Program bulletin, 1974, Volume: 12, Issue:2

    Topics: Age Factors; Amphetamine; Anesthesia, General; Animals; Aphasia; Brain Injuries; Brain Mapping; Cats

1974